What "Lean" Means in Regulatory Consulting: 3 Principles That Cut Waste

Why Lean Matters in Regulatory Consulting

Medical device regulatory consulting has historical patterns of inefficiency:

• 200-page submissions when 80 pages would clear MFDS
• Junior consultants drafting first, senior reviewing last (with multiple rounds)
• Time-and-materials billing where scope expands beyond initial estimate
• Documentation prepared because "we always do it this way," not because it's required

Leanabl's lean approach addresses each of these.

Principle 1: No Wasted Motion

"Every deliverable answers a regulatory question. If it doesn't, we don't write it."

What Wasted Motion Looks Like

The bloated Korean STED:

• 350-page submission to MFDS
• 60% of pages are CE Annex II content reformatted without regulatory necessity
• Reviewer takes longer to find substantive content
• Deficiency rate similar to leaner submissions

The over-documented risk file:

• 200-page risk management file for Class II device
• 80% of content is template language not specific to device
• Risk decisions buried in template noise

The over-engineered clinical evaluation:

• 100-page CER citing 500+ references
• Most references tangentially relevant
• Korean clinical context discussion missing despite document length

What Lean Looks Like

Right-sized Korean STED:

• 120 pages with focused content
• Each section answers specific MFDS evaluation question
• Korean translations of substantive content only
• Faster review, same approval rate

Targeted risk file:

• 40-page risk management file for Class II
• Device-specific risks documented; template language minimized
• Risk control decisions clear and traceable

Focused clinical evaluation:

• 30-page CER citing 30 high-relevance references
• Korean clinical context discussed
• Conclusions defendable

How "No Wasted Motion" Reduces Approval Time

• Reviewers find substantive content faster
• Fewer deficiency notices (questions about template content)
• Lower documentation maintenance burden
• Easier to update for changes

Principle 2: The Work, Not the Show

"Senior practitioners do the work. No pyramid billing. The person on the call is the person on the file."

What "The Show" Looks Like

Traditional consulting model:

• Senior partner sells the engagement (high credibility)
• Junior consultant drafts deliverables (90% of work)
• Senior partner reviews and adjusts (10% of work)
• Multiple rounds of senior-junior iteration
• Client communication via account manager
• High billing rates for senior; high hours from junior

Result: Client pays premium rates for output that's mostly junior work, with senior involvement only at delivery and review.

What "The Work" Looks Like

Leanabl model:

• Senior practitioner (10+ years regulatory experience) handles engagement end-to-end
• Senior drafts, reviews, and delivers
• Client communication with the same senior who does the work
• No translation layer between client and practitioner
• Fewer total hours, higher per-hour rate, lower total cost

Result: Client gets senior-quality output with direct senior access, often at lower total cost.

Why This Works for Specialized Domains

Medical device regulatory work is highly specialized. The compounding effect of senior expertise:

• Faster issue identification (5 minutes vs 5 hours)
• Better technical writing (clearer regulatory communication)
• More effective negotiation with regulators
• Fewer rounds of revision

For commodity work, junior-led delivery makes sense. For specialized regulatory work, senior-led is more efficient.

Principle 3: Priced Before You Commit

"Fixed-fee where the path is known. Named risks where it isn't. You see the number before you sign."

What Traditional Pricing Looks Like

Time and materials:

• Hourly rates disclosed
• Scope ambiguous
• Hours expand beyond initial estimate
• Client receives monthly bills with surprise
• Total cost unknown until project end

Retainer:

• Monthly fee disclosed
• Scope flexible
• Effective hourly cost unclear
• Difficult to budget

"Discovery first" pricing:

• Initial consultation paid
• Then proposal arrives with much higher number
• Client locked into relationship

What Leanabl Pricing Looks Like

Fixed-fee scoped engagements:

• Scope defined explicitly
• Fixed price disclosed before contract
• Inclusions and exclusions specified
• Change orders priced separately

Named risks:

• Where scope cannot be fully fixed, risks named
• Risk-based pricing tiers explained
• Client decides risk acceptance
• No surprise overruns

Examples

Fixed-fee scoping:

• Korean STED preparation for Class II device with existing CE file: $30K
• KGMP gap analysis: $25K
• KLH service annual: $15K
• License renewal management (single product): $8K

Named risks:

• Korean clinical study (if required): $200K–$500K based on enrollment requirements
• KGMP inspection findings remediation: $20K–$50K based on findings severity
• MFDS deficiency response: $5K–$15K per round

Client sees the range; can plan budget; no surprise.

Operating Patterns That Result

Pattern 1: Smaller Engagement Teams

Where traditional consulting deploys 3–5 person teams (junior + senior + account manager), Leanabl deploys 1–2 person teams (senior + occasional specialist).

Pattern 2: Faster Initial Response

Senior practitioner responds to client questions directly within hours, not days. No account manager intermediary.

Pattern 3: Direct Documentation Access

Client sees draft deliverables in real-time. No "delivery event" surprise.

Pattern 4: Fewer but Better Touch Points

Weekly status calls instead of daily, but each call is substantive. Less meeting overhead, more progress.

Pattern 5: Predictable Project Closure

Projects close when scope is complete, not when budget runs out. Clean handover.

What This Means for Clients

For Medical Device Manufacturers

• Faster regulatory clearance (smaller, targeted submissions)
• Lower total cost (senior efficiency)
• Predictable budgets (fixed-fee or named-risk pricing)
• Direct senior access (no account manager)
• Tighter project closure (no scope creep)

For Regulatory Affairs Leaders

• Less internal management overhead
• Higher quality external deliverables
• Better budget defensibility
• Clearer accountability

Frequently Asked Questions

Q: How can senior-led be cheaper than junior-led?

A: Senior practitioners take fewer hours for the same work due to experience. Even at higher hourly rates, total cost is often lower. Plus avoided rework and deficiency cycles.

Q: What if scope changes mid-engagement?

A: Change orders priced separately and disclosed in writing. Original scope remains fixed-fee; additions priced fairly.

Q: Are there situations where time-and-materials makes more sense?

A: For highly exploratory projects with truly unknown scope. Most regulatory work is well-defined enough for fixed-fee or named-risk pricing.

Q: Is Leanabl always cheaper than alternatives?

A: Not always. For commodity work, larger consulting firms may price lower. For specialized regulatory work requiring senior expertise, Leanabl is typically cheaper and faster.

Q: How do you maintain senior-led model at scale?

A: By limiting client load per senior practitioner and refusing to take on engagements that would compromise senior involvement.

How Leanabl Helps

These principles run through all Leanabl services:

• Korea Medical Device Registration — lean Korean STED preparation
• KGMP Certification — focused remediation, no over-engineering
• KLH Service — senior practitioner KLH model
• Mission & Vision — read more about Leanabl's philosophy

Contact Leanabl to discuss your regulatory needs.

---

Last updated: 2026-05-15.